Pfizer Inc.

38.97-0.1200-0.31%Vol 19.69M1Y Perf -24.51%
Jun 9th, 2023 16:03 DELAYED
BID38.94 ASK38.98
Open39.28 Previous Close38.97
Pre-Market- After-Market39.01
 - -  0.04 0.10%
Target Price
57.40 
Analyst Rating
Moderate Buy 2.20
Potential %
47.29 
Finscreener Ranking
★★★+     51.81
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     53.95
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     68.88
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★★★     50.71
Price Range Ratio 52W %
14.93 
Earnings Rating
Neutral
Market Cap220.00B 
Earnings Date
27th Jul 2023
Alpha0.00 Standard Deviation0.08
Beta0.64 

Today's Price Range

38.8739.59

52W Range

36.1754.93

5 Year PE Ratio Range

8.9036.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.59%
1 Month
1.75%
3 Months
-1.07%
6 Months
-24.65%
1 Year
-24.51%
3 Years
16.83%
5 Years
6.27%
10 Years
49.29%

TickerPriceChg.Chg.%
PFE38.97-0.1200-0.31
AAPL180.960.39000.22
GOOG122.870.20000.16
MSFT326.791.53000.47
XOM107.39-0.8000-0.74
WFC42.13-0.2400-0.57
JNJ160.01-0.2500-0.16
FB---
GE106.300.23000.22
JPM141.010.28000.20
ProfitabilityValueIndustryS&P 500US Markets
65.50
34.60
39.50
9.70
34.72
RevenueValueIndustryS&P 500US Markets
76.04B
13.55
14.63
6.29
DividendsValueIndustryS&P 500US Markets
3.39
1.64
3.87
5.00
Payout ratio92.00
Earnings HistoryEstimateReportedSurprise %
Q01 20231.001.2323.00
Q04 20221.031.1410.68
Q03 20221.471.7821.09
Q02 20221.752.0416.57
Q01 20221.661.62-2.41
Q04 20210.851.0827.06
Q03 20211.081.3424.07
Q02 20210.971.0710.31
Earnings Per EndEstimateRevision %Trend
6/2023 QR0.63-4.55Negative
9/2023 QR0.69-19.77Negative
12/2023 FY3.350.60Positive
12/2024 FY3.33-13.95Negative
Next Report Date27th Jul 2023
Estimated EPS Next Report0.63
Estimates Count7
EPS Growth Next 5 Years %9.00
Volume Overview
Volume19.69M
Shares Outstanding5.65M
Shares Float5.61B
Trades Count139.97K
Dollar Volume770.21M
Avg. Volume24.15M
Avg. Weekly Volume20.24M
Avg. Monthly Volume28.47M
Avg. Quarterly Volume23.74M

Pfizer Inc. (NYSE: PFE) stock closed at 38.97 per share at the end of the most recent trading day (a -0.31% change compared to the prior day closing price) with a volume of 19.69M shares and market capitalization of 220.00B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 78500 people. Pfizer Inc. CEO is Albert Bourla.

The one-year performance of Pfizer Inc. stock is -24.51%, while year-to-date (YTD) performance is -23.95%. PFE stock has a five-year performance of 6.27%. Its 52-week range is between 36.17 and 54.93, which gives PFE stock a 52-week price range ratio of 14.93%

Pfizer Inc. currently has a PE ratio of 9.80, a price-to-book (PB) ratio of 3.09, a price-to-sale (PS) ratio of 3.57, a price to cashflow ratio of 11.00, a PEG ratio of 2.32, a ROA of 17.15%, a ROC of 25.39% and a ROE of 37.98%. The company’s profit margin is 34.72%, its EBITDA margin is 39.50%, and its revenue ttm is $76.04 Billion , which makes it $13.55 revenue per share.

Of the last four earnings reports from Pfizer Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Pfizer Inc.’s next earnings report date is 27th Jul 2023.

The consensus rating of Wall Street analysts for Pfizer Inc. is Moderate Buy (2.2), with a target price of $57.4, which is +47.29% compared to the current price. The earnings rating for Pfizer Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Pfizer Inc. has a dividend yield of 3.39% with a dividend per share of $1.64 and a payout ratio of 92.00%.

Pfizer Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.45, ATR14 : 0.81, CCI20 : 108.02, Chaikin Money Flow : 0.03, MACD : 0.00, Money Flow Index : 71.16, ROC : -1.69, RSI : 54.49, STOCH (14,3) : 65.49, STOCH RSI : 0.86, UO : 50.07, Williams %R : -34.51), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Pfizer Inc. in the last 12-months were: Albert Bourla (Option Excercise at a value of $6 058 579), Angela Hwang (Option Excercise at a value of $464 049), Douglas M. Lankler (Option Excercise at a value of $2 672 547), Hwang Angela (Option Excercise at a value of $1 720 655), Jennifer B. Damico (Option Excercise at a value of $570 681), Jennifer B. Damico (Sold 9 912 shares of value $396 678 ), Johnson Rady (Option Excercise at a value of $1 722 445), Michael McDermott (Option Excercise at a value of $324 534), Mikael Dolsten (Option Excercise at a value of $2 627 259), Payal Sahni (Option Excercise at a value of $204 202), Rady A. Johnson (Option Excercise at a value of $770 340), Sahni Payal (Option Excercise at a value of $663 057), Sally Susman (Option Excercise at a value of $1 670 603), Susman Sally (Option Excercise at a value of $3 964 820)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (40.00 %)
6 (40.00 %)
6 (42.86 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
9 (60.00 %)
9 (60.00 %)
8 (57.14 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.20
Moderate Buy
2.20
Moderate Buy
2.14

Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

CEO: Albert Bourla

Telephone: +1 212 733-2323

Address: 235 East 42nd Street, New York 10017, NY, US

Number of employees: 78 500

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

44%56%

Bearish Bullish

60%40%

Bearish Bullish

54%46%

 

TipRanks News for PFE

Wed, 07 Jun 2023 09:55 GMT Pfizer (PFE) Receives a Hold from SVB Securities

- TipRanks. All rights reserved.

Wed, 03 May 2023 11:01 GMT Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Sarepta Therapeutics (SRPT) and Rhythm Pharmaceuticals (RYTM)

- TipRanks. All rights reserved.

Tue, 02 May 2023 13:00 GMT Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Harmony Biosciences Holdings (HRMY)

- TipRanks. All rights reserved.

Fri, 07 Apr 2023 06:50 GMT Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), NeoGenomics (NEO) and Pharvaris (PHVS)

- TipRanks. All rights reserved.

Mon, 06 Mar 2023 08:35 GMT Pfizer (PFE) Receives a Hold from Jefferies

- TipRanks. All rights reserved.

Wed, 01 Feb 2023 14:05 GMT Pfizer (PFE) Gets a Buy from BMO Capital

- TipRanks. All rights reserved.

News

Stocktwits